The nation of Zimbabwe has declined a substantial US healthcare agreement valued at $367m (272 million pounds) over five years over the United States' insistence on sensitive data.
This move became public following a internal memorandum from December was leaked, which showed President Emmerson Mnangagwa deemed the deal was "unbalanced".
A government representative has since explained that the US was seeking health data for scientific study and profit while refused to share the resulting advantages from any future medical innovations.
"We are forced to start the challenging and unfortunate process of scaling back our health assistance in Zimbabwe," said American envoy to Zimbabwe Pamela Tremont in a statement.
Her embassy indicated the US had furnished over $1.9bn for health programmes to Zimbabwe over the last two decades.
A physicians' group in Zimbabwe has urged continued talks to find a agreement acceptable to both sides so the nation's critical HIV treatment initiative can be sustained.
Wider Implications
This development follows a comparable situation in neighbouring Kenya, where a high court halted a similar health funding agreement after legal challenges were raised about the safety of Kenyans' health data.
Since returning to office recently, US President Donald Trump has reduced foreign aid and closed the US Agency for International Development (USAID).
USAID had overseen aid for the US government, but Trump stated its spending was "wasteful" and his administration was seeking direct bilateral agreements to enhance transparency and responsibility.
Based on reports, 16 nations in Africa have so far signed similar health pacts, representing over $18.3bn in committed funds.
Specifics of the Rejected Deal
The funds for Zimbabwe would have funded "combating HIV/Aids, TB, malaria, maternal and child health, and disease outbreak preparedness.
"It is our view this cooperation could have provided extraordinary benefits for Zimbabwean communities, especially the 1.2 million men, women and children presently on HIV treatment through American-funded programmes," Tremont commented.
However, official spokesman Nick Mangwana said the arrangement was "asymmetrical".
"The proposal required Zimbabwe to surrender its biological resources and data for a long time, without any equivalent promise of access to any medical innovations – like new medicines or tests – that might result from that shared data," Mangwana explained.
"Put simply, our country would supply the basic resources for scientific discovery without any certainty that the final treatments would be accessible to our population should a new health crisis arise."
Sovereignty and Global Health
Mangwana further said that the US's withdrawal from the World Health Organization (WHO) and its push of bilateral deals were upending frameworks previously established via the international organization.
The spokesperson gave as an example its Pandemic Benefit-Sharing scheme created to deal with future pandemics.
"This mechanism is intended to guarantee that when a country contributes its samples, the resulting advantages – including medicines and cures – are shared equitably, not monopolised solely by those with the funds to develop them."
These objections regarding the US deal "must not be interpreted as hostility towards the US," Mangwana stressed.
"We encourage ongoing dialogue with our US partners on how future collaboration might be arranged in a manner that respects the sovereignty and dignity of both nations."
Medical Community Response
The Zimbabwe College of Public Health Physicians (ZCPHP) expressed it recognised the government's concerns, but urged that negotiations need to persist given that a large portion of the nation's HIV programmes depended on international support.
"Where specific concerns arise, including those involving information security or implementation frameworks, these can frequently be resolved through detailed discussion and negotiated safeguards," it commented.
The situation emphasises the continuing debate between receiving much-needed foreign assistance and protecting local interests in an increasingly data-driven world.